Bispecific Antibody Revolution: Harness Your Immune System Against #Myeloma | Hans Lee, MD

At the HealthTree Multiple Myeloma RoundTable in Nashville, Hans Lee, MD, explains the bispecific antibody revolution in the treatment of Multiple Myeloma.

Bispecific antibodies are one of the most exciting advances in myeloma therapy. These innovative treatments work by harnessing the power of your immune system, bringing T-cells directly to myeloma cells so they can recognize and destroy the cancer.

In this session, Dr. Lee breaks down how bispecific therapies work, why they represent a major shift in treatment, and what patients should understand about their benefits, risks, and where they fit into the myeloma treatment landscape.